Author

Arteid Memaj 1

1 Bristol Myers Squibb, Princeton, United States

EVALUATION OF OZANIMOD EFFICACY AND SAFETY IN OLDER PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE PHASE 3 TRUE NORTH STUDY

Peter Irving, Ashwin N. Ananthakrishnan, Irina Blumenstein, Sara Horst, HARRIS AHMAD, Garrett Lawlor, Vanessa Hobbs, Anjali Jain, Arteid Memaj, Nabeel Khan

EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Remo Panaccione, Anita Afzali, David P. Hudesman, Garrett Lawlor, Mark T. Osterman, Arteid Memaj, Miguel Regueiro, Subrata Ghosh

OZANIMOD EFFICACY BY BASELINE ENDOSCOPIC DISEASE DISTRIBUTION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: A POST HOC ANALYSIS FROM TRUE NORTH

Axel Dignass, Anita Afzali, Monika Fischer, Charles Sninsky, Alessandro Armuzzi, Chun Wu, HARRIS AHMAD, Arteid Memaj, Sarah Harris, James Canavan, Stefan Schreiber

OZANIMOD IS AN EFFECTIVE ORAL TREATMENT FOR PATIENTS WITH ULCERATIVE COLITIS REGARDLESS OF MODERATE OR SEVERE ENDOSCOPIC DISEASE ACTIVITY: A POST HOC ANALYSIS OF TRUE NORTH

Laurent Peyrin-Biroulet, Remo Panaccione, Irina Blumenstein, Millie Long, Bincy P. Abraham, Anjali Jain, Arteid Memaj, Chun Wu, Vanessa Hobbs, Sarah Harris, James Canavan, Douglas C. Wolf

RECAPTURE OF RESPONSE WITH OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO WITHDREW THERAPY: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Anita Afzali, Michael Chiorean, Garrett Lawlor, Mark T. Osterman, Arteid Memaj, Remo Panaccione, Subrata Ghosh

Item 1 - 5 / 5
1